Type something to search the website
Library

Mirabegron Mechanism of Action

1 October 2015. doid: 10.1111/bcp.12647

Goulooze SC, Cohen AF, Rissmann R

View publication

Abstract

Mirabegron is used for the treatment of symptoms associated with overactive bladder syndrome. It selectively stimulates the β3-adrenoreceptor, which relaxes the detrusor muscle. This improves urine storage by distension of the bladder body.

Advancing the boundaries of clinical drug development

Wondering how we can help you? Reach out to us.

Get in contact Get in contact USA
contact